Recombinant Dog Gap junction alpha-1 protein (GJA1)

What functional domains of recombinant dog GJA1 are critical for experimental applications?

Several functional domains are critical when working with recombinant dog GJA1:

The C-terminal region (AA 255-382) is particularly important as NMR studies show it has a random coil structure with two short α-helices, allowing for numerous interactions with different proteins while forming higher-order structures . The region AA 234-243 contains a putative tubulin-binding sequence that is unique to GJA1 and not conserved in other gap junction protein families .

What expression systems yield optimal functional recombinant dog GJA1 and what are their comparative advantages?

Different expression systems for recombinant dog GJA1 offer varying advantages:

For E. coli expression, protocols typically include:

• Expression with N-terminal His-tag for purification

• Lyophilization for storage

• Reconstitution in appropriate buffer systems (Tris/PBS-based buffer, pH 8.0)

• Addition of 5-50% glycerol (final concentration) for long-term storage at -20°C/-80°C

Researchers should consider the experimental application when selecting an expression system. For studies focusing on channel formation and cell-cell communication, mammalian expression systems may be preferable despite lower yields .

How can post-translational modifications of dog GJA1 be accurately characterized and their functional significance assessed?

Characterizing post-translational modifications (PTMs) of dog GJA1 requires multiple complementary approaches:

• Phosphorylation analysis techniques:

  • Western blotting with phospho-specific antibodies (e.g., anti-phospho-Connexin 43/GJA1 (S368))

  • Lambda phosphatase treatment to confirm phosphospecificity

  • Mass spectrometry for comprehensive phosphorylation site mapping

• Functional assessment of phosphorylation:

  • Site-directed mutagenesis of phosphorylation sites

  • Comparison of wild-type and phospho-mutant proteins in trafficking assays

  • Gap junction plaque formation analysis using immunofluorescence

  • Dye transfer assays to assess channel permeability

• Ubiquitination analysis:

  • Immunoprecipitation combined with ubiquitin-specific antibodies

  • Mass spectrometry to identify ubiquitination sites

  • Proteasome inhibitor treatments to assess degradation pathways

Research has shown that phosphorylation at S368 by Protein Kinase C delta causes movement of Connexin 43 within gap junctions, followed by vesicle internalization and protein degradation. This can be visualized using immunofluorescence microscopy and quantified through western blot analysis .

How can recombinant dog GJA1 be used to study the novel GJA1-20k isoform and its role in actin organization?

GJA1-20k, an N-terminus truncated isoform of Connexin 43, has emerged as a critical regulator of actin organization and mitochondrial protection. Research methodologies include:

• Direct binding assays:

  • Cell-free TIRF (Total Internal Reflection Fluorescence) imaging of purified GJA1-20k with actin

  • Co-sedimentation assays to quantify binding affinity

  • FRET (Förster Resonance Energy Transfer) analysis to measure interaction dynamics

• Structural analysis:

  • 3D reconstruction of "mitochondrial actin cages" formed by GJA1-20k

  • High-resolution confocal microscopy of GJA1-20k and actin organization around mitochondria

• Functional studies:

  • Ischemia-reperfusion models to assess GJA1-20k's protective effects

  • Live-cell imaging of mitochondrial dynamics under stress conditions

  • Assessment of mitochondrial swelling in the presence/absence of GJA1-20k

Cell-free TIRF imaging has established that GJA1-20k directly binds to actin, forming both actin clusters and stabilized actin filaments. This binding results in a rich collection of actin around mitochondria, forming dense actin sheets ("mitochondrial actin cages") that appear to limit mitochondrial swelling under stress conditions .

What methodologies are most effective for studying GJA1's role in cilia formation and function?

To investigate GJA1's role in cilia formation and function, researchers can employ these approaches:

• Loss-of-function studies:

  • siRNA-mediated depletion of GJA1 in human RPE1 cells

  • CRISPR/Cas9-mediated mutagenesis targeting GJA1

  • Dominant-negative mutants (T154A point mutation, Δ130–136 deletion, Δ234–243 deletion)

• Visualization techniques:

  • Immunofluorescence analysis using acetylated tubulin antibody to detect ciliary axonemes

  • Co-immunostaining of GJA1 with trans-Golgi marker TGN46 or pericentriolar material marker BBS4

  • Live imaging of cilia formation and dynamics

• Quantitative measurements:

  • Counting acetylated tubulin-positive cells to quantify ciliated cells

  • Measuring the length of isolated cilia

  • Analyzing basal body formation and localization

• Molecular interaction studies:

  • Immunoprecipitation with anti-GJA1 antibody-conjugated paramagnetic beads

  • Mass spectrometry to identify GJA1-interacting proteins

  • Validation of interactions through co-immunoprecipitation and co-localization studies

Research has shown that GJA1 depletion significantly disrupts cilia formation in RPE1 cells, with GJA1 accumulating in pericentriolar regions where the primary cilium originates. This suggests GJA1 plays a role in primary cilium formation by affecting trafficking around pericentriolar regions involved in cilia formation .

How can cryo-electron microscopy be optimized for structural analysis of recombinant dog GJA1 gap junction channels?

Optimizing cryo-electron microscopy (cryo-EM) for structural analysis of recombinant dog GJA1 gap junction channels involves multiple technical considerations:

• Sample preparation:

  • Expression of full-length recombinant dog GJA1 with minimal tags

  • Reconstitution in lipid nanodiscs to mimic native membrane environment

  • Testing various detergents including cholesteryl hemisuccinates which shift conformational equilibrium to gate-covering (GCN) state

• Data collection parameters:

  • Voltage: Typically 300 kV for high-resolution data

  • Defocus range: -1.0 to -3.0 μm to enhance contrast

  • Dose: Minimizing beam damage while maintaining signal-to-noise ratio

  • Tilt series: For tomographic reconstruction of gap junction plaques

• Conformational state analysis:

  • Identification of N-terminal helix conformations (GCN, PLN, FIN)

  • Analysis of conformation distribution in different conditions

  • Assessment of α-to-π-helix transitions in the first transmembrane helix

• Validation approaches:

  • Comparison with alternative structural methods (X-ray crystallography, NMR)

  • Mutagenesis of key residues identified in structural analysis

  • Functional correlation using dye transfer or electrophysiological methods

Recent cryo-EM studies have revealed that recombinant GJA1 exists in a dynamic equilibrium state with various channel conformations, including three different N-terminal helix conformations that are randomly distributed in purified gap junction intercellular channel particles. The conformational equilibrium can be shifted by factors such as cholesteryl hemisuccinates, C-terminal truncations, and pH changes .

What are the most common challenges in producing functional recombinant dog GJA1 and how can they be addressed?

Researchers face several challenges when producing functional recombinant dog GJA1:

For optimal results, researchers should monitor protein quality at each step using techniques such as circular dichroism to assess secondary structure, size-exclusion chromatography to detect aggregation, and functional assays to confirm channel-forming ability .

How can researchers resolve contradictory data regarding GJA1 localization and trafficking in different experimental systems?

Resolving contradictory data regarding GJA1 localization and trafficking requires systematic analysis:

• Standardize detection methods:

  • Use validated antibodies specific to different domains of GJA1

  • Compare multiple antibodies targeting different epitopes

  • Employ epitope-tagged recombinant GJA1 for consistent detection

  • Validate specificity through knockdown/knockout controls

• Account for cellular context differences:

  • Document cell type-specific variations in GJA1 localization

  • Analyze the expression of trafficking machinery components

  • Consider cell density and junction formation status

  • Evaluate the influence of cell polarization status

• Reconcile contradictory findings:

  • In epithelial cells: GJA1 shows dual localization at gap junctions and in pericentriolar regions

  • In cardiac cells: GJA1-20k contributes to trafficking by arranging actin to guide full-length Cx43 delivery

  • During epithelial-mesenchymal transition: Altered translation initiation of GJA1 limits gap junction formation

• Methodological considerations:

  • Live imaging versus fixed cell analysis

  • Overexpression artifacts versus endogenous protein

  • 2D versus 3D culture systems

  • Time-course analyses to capture dynamic localization changes

Research has shown that GJA1 localization varies significantly between cell types. In RPE1 cells, GJA1 localizes to gap junctions at cell periphery and accumulates in pericentriolar regions, while in Xenopus epithelial tissues, it shows ciliary localization. These differences highlight the importance of cellular context in GJA1 trafficking and function .

What are the essential controls and validation steps needed when studying dominant-negative mutations of dog GJA1?

When studying dominant-negative mutations of dog GJA1, comprehensive controls and validation steps are crucial:

• Mutation design and validation:

  • Sequence verification of all constructs

  • Protein expression confirmation by western blot

  • Half-life assessment to rule out stability differences

  • In vitro Cas9 reaction testing for CRISPR-based approaches

• Functional validation:

  • Gap junction formation assessment by immunofluorescence

  • Channel permeability using dye transfer assays (e.g., Lucifer yellow)

  • Electrical coupling measurements in cell pairs

  • Comparison with known dominant-negative mutants (T154A, Δ130–136)

• Rescue experiments:

  • Co-transfection with siRNA-non-targetable wild-type GJA1

  • Dose-dependent rescue to establish dominant-negative effect

  • Phenotype quantification before and after rescue

• Mechanistic analysis:

  • Determine if mutation affects assembly, trafficking, or channel function

  • Assess interaction with wild-type protein through co-immunoprecipitation

  • Analyze subcellular localization changes

  • Evaluate effects on interacting partners

Research on three dominant-negative mutants (T154A point mutation, Δ130–136 deletion mutation, and Δ234–243 deletion mutation) has shown that each causes severe defects in cilia formation. Immunofluorescence analysis revealed shortened and fewer ciliary axonemes in mutant-expressing embryos, with the number of ciliated cells significantly reduced compared to controls. Importantly, the Δ234–243 mutant, which affects the tubulin-binding sequence unique to GJA1, showed the most pronounced effect on cilia number .

How can recombinant dog GJA1 be used to investigate its role in mitochondrial protection during cardiac stress?

Recent research has revealed GJA1's unexpected role in mitochondrial protection during cardiac stress, particularly through its truncated isoform GJA1-20k. Investigation approaches include:

• Mitochondrial function assessment:

  • Measure mitochondrial membrane potential using fluorescent indicators

  • Assess mitochondrial respiration with Seahorse XF analysis

  • Evaluate ROS production during simulated ischemia-reperfusion

  • Analyze mitochondrial calcium handling under stress conditions

• Actin cage formation analysis:

  • High-resolution confocal microscopy to visualize actin organization around mitochondria

  • 3D reconstruction of actin cages

  • Live-cell imaging to track actin dynamics during stress responses

  • Correlative light and electron microscopy for ultrastructural analysis

• Therapeutic potential assessment:

  • Delivery of recombinant GJA1-20k in cardiac injury models

  • Evaluation of cell-cell coupling maintenance during acute ischemia

  • Measurement of infarct size reduction in GJA1-20k-treated hearts

  • Assessment of long-term cardiac function after ischemic injury

Research has demonstrated that GJA1-20k directly binds to actin, forming stabilized actin filaments that create "mitochondrial actin cages." These structures appear to prevent pathological mitochondrial swelling during oxidative stress, potentially explaining GJA1-20k's protective effects against ischemia-reperfusion injury .

What novel approaches can be used to study GJA1's role in epithelial-mesenchymal transition (EMT)?

Studying GJA1's role in epithelial-mesenchymal transition requires innovative approaches:

• Translation regulation analysis:

  • Assessment of internal translation initiation producing truncated GJA1 isoforms

  • Analysis of PI3K/Akt/mTOR pathway activation during EMT

  • Polysome profiling to determine translational efficiency of GJA1 mRNA

  • Use of translation inhibitors to modulate GJA1 isoform production

• Protein stability and turnover:

  • Pulse-chase experiments to measure GJA1 half-life during EMT

  • Ubiquitination analysis through immunoprecipitation

  • Proteasome and lysosome inhibitor treatments

  • Live-cell imaging of fluorescently tagged GJA1 during EMT

• Functional consequences:

  • Gap junction communication assessment using dye transfer

  • Electrical coupling measurements during EMT progression

  • Correlation of GJA1 isoform expression with invasion and migration

  • Restoration of gap junction function through targeted approaches